Skip to main content
FluentFlash

Substance Use Disorders Flashcards: Complete Study Guide

·

Substance use disorders (SUDs) represent one of the most clinically important topics in abnormal psychology. You need to master diagnostic criteria, neurobiological mechanisms, treatment approaches, and how different substances affect the brain and behavior.

Flashcards work particularly well for SUDs because they help you quickly recall DSM-5 diagnostic criteria, identify symptoms across substance classes, and understand addiction progression. This material covers neurobiology, evidence-based treatments, and clinical understanding needed for exams and professional practice.

Substance use disorders flashcards - study with AI flashcards and spaced repetition

Understanding Substance Use Disorders and Diagnostic Criteria

Substance use disorders are defined by the DSM-5 as cognitive, behavioral, and physiological symptoms showing continued substance use despite serious problems. The diagnostic system focuses on 11 specific symptoms that must appear within a 12-month period.

The 11 DSM-5 Diagnostic Criteria

These criteria include:

  • Tolerance: needing increased amounts for desired effects
  • Withdrawal: physical and psychological symptoms when use stops
  • Unsuccessful control efforts
  • Continued use despite knowing it causes problems
  • Neglect of other activities in favor of substance use

Severity ranges from mild (2-3 criteria) to moderate (4-5 criteria) to severe (6 or more criteria). This system replaces the outdated abuse versus dependence distinction.

Key Definitions to Master

Students often confuse related terms. Tolerance means needing more substance for the same effect. Withdrawal involves physical and psychological symptoms when substance use stops. Craving is intense desire for a substance (different from withdrawal). Flashcards help you distinguish these precisely.

The DSM-5 organizes SUD diagnoses by substance class. Cocaine, alcohol, opioids, and cannabis each produce different use patterns and consequences. Your studying should focus on both universal SUD criteria and substance-specific factors.

Neurobiological Mechanisms and the Brain's Reward System

Substance use disorders are brain disorders affecting the reward system. Most addictive substances increase dopamine in the nucleus accumbens, creating powerful reinforcement for repeated use. This biological understanding explains addiction as a medical condition, not a moral failing.

How Different Substances Affect Dopamine

Substances increase dopamine through different mechanisms:

  • Stimulants (cocaine, methamphetamine): block dopamine reuptake
  • Opioids: activate opioid receptors and indirectly increase dopamine
  • Alcohol: enhances GABA and increases dopamine
  • Nicotine: activates acetylcholine receptors and increases dopamine

Neuroadaptation and Loss of Control

Neuroadaptation happens when the brain adjusts to chronic substance use. The reward system becomes less sensitive to natural rewards and increasingly focused on drug-seeking. This explains tolerance, since the brain requires escalating doses for the same dopaminergic response.

The prefrontal cortex, responsible for decision-making and impulse control, becomes compromised in addiction. This reduces the person's ability to resist cravings despite knowing the negative consequences. Sensitization also matters: repeated exposure to drug-associated cues intensifies cravings, explaining why environmental triggers remain powerful even after long sobriety.

Substance Classes, Effects, and Withdrawal Syndromes

Different substance classes produce distinct physiological and behavioral effects. Understanding these differences is essential for diagnosis and treatment planning.

Depressants: Alcohol, Benzodiazepines, Barbiturates

These suppress central nervous system activity. Alcohol withdrawal can be life-threatening, potentially causing seizures and delirium tremens (hallucinations, disorientation, autonomic hyperactivity). Benzodiazepine withdrawal mirrors alcohol withdrawal and also carries serious medical risks.

Stimulants: Cocaine, Methamphetamine, Prescription Amphetamines

Stimulants increase dopamine and norepinephrine, producing euphoria and enhanced focus. Stimulant withdrawal is typically not medically dangerous but produces severe psychological symptoms: depression, anhedonia (inability to experience pleasure), fatigue, and intense cravings.

Opioids: Heroin, Prescription Painkillers, Fentanyl

Opioids produce analgesia and euphoria. Opioid withdrawal is rarely life-threatening in healthy individuals but produces severe discomfort: muscle aches, sweating, anxiety, and gastrointestinal distress.

Other Substance Classes

Hallucinogens (LSD, psilocybin) rarely produce physical dependence but can trigger persistent perceptual changes. Cannabis withdrawal produces irritability, sleep problems, and anxiety. Nicotine is highly addictive with significant withdrawal including anxiety and intense cravings. MDMA (ecstasy) affects serotonin and causes depression with chronic use.

Flashcards should organize substances by primary effects, withdrawal syndromes, and health consequences for rapid recall and comparison.

Risk Factors, Vulnerability, and Co-occurring Disorders

Substance use disorders result from complex interactions between biological, psychological, and social factors. No single cause determines addiction; rather, multiple factors accumulate to create vulnerability.

Biological and Environmental Risk Factors

Genetic vulnerability accounts for approximately 40-60% of addiction risk, varying by substance class. Family history predicts risk, but genes do not determine destiny. Environmental factors include:

  • Early substance exposure (before age 15 significantly increases risk)
  • Peer influence
  • Family dysfunction and trauma
  • Stress and substance availability

Psychological Factors and Self-Medication

Psychological risk factors include impulse control difficulties, sensation-seeking traits, anxiety, depression, and other mental health conditions. The self-medication hypothesis suggests individuals with untreated mental illness may use substances to manage symptoms.

Co-occurring Disorders Complicate Treatment

Co-occurring disorders are extremely common. Approximately 50% of individuals with an SUD have comorbid mental health conditions, most frequently depression, anxiety, bipolar disorder, and PTSD. Addressing only addiction without treating underlying mental health often leads to relapse.

Protective Factors and Recovery

Protective factors reduce SUD risk: strong family relationships, academic success, religious involvement, good coping skills, and treatment access. This biopsychosocial understanding shows addiction requires comprehensive, individualized treatment.

Evidence-Based Treatment Approaches and Recovery Models

Effective treatment for SUDs involves multiple approaches, often combined in comprehensive programs. The biopsychosocial approach integrates medication, psychotherapy, family involvement, and lifestyle changes.

Medication-Assisted Treatment (MAT)

MAT uses medications to reduce cravings or block euphoric effects. For opioid use disorder, buprenorphine or methadone combined with behavioral therapy produces retention rates above 60%. For alcohol use disorder, naltrexone reduces craving and acamprosate restores neurotransmitter balance, though medication alone rarely suffices without psychotherapy.

Behavioral and Psychological Therapies

Cognitive-behavioral therapy (CBT) helps identify substance-use triggers, develop coping strategies, and modify thoughts maintaining addiction. Contingency management provides incentives for drug-free urine tests. Motivational interviewing helps individuals explore their own reasons for change rather than receiving external motivation.

Community Support and Structured Treatment

Peer support groups including 12-step programs (AA, NA) and SMART Recovery provide community and accountability. Residential treatment programs provide structured environments and intensive treatment, particularly for severe cases. Family therapy addresses dysfunctional patterns and involves families in recovery.

Managing Relapse

Relapse occurs in approximately 40-60% of individuals with SUDs and should be viewed as a temporary setback, not treatment failure. Successful recovery often requires multiple treatment attempts and adjustments. Flashcards help you organize treatments by mechanism, applicable disorders, evidence of effectiveness, and appropriate settings.

Start Studying Substance Use Disorders

Master diagnostic criteria, neurobiological mechanisms, substance classes, withdrawal syndromes, and evidence-based treatments with interactive flashcards. Optimize your abnormal psychology exam preparation with spaced repetition and active recall.

Create Free Flashcards

Frequently Asked Questions

What is the difference between substance abuse and substance use disorder?

The DSM-5 eliminated the distinction between substance abuse and dependence, creating one diagnosis: substance use disorder with severity levels (mild, moderate, severe). Historically, substance abuse meant problematic use causing functional impairment without physical dependence. Dependence emphasized tolerance and withdrawal. This change reflects the understanding that psychological addiction (craving, continued use despite consequences) is as clinically significant as physical dependence. Someone can have severe cocaine consequences without obvious withdrawal, or develop alcohol tolerance without meeting abuse criteria. This unified approach recognizes addiction as a spectrum disorder with integrated behavioral and physiological components.

Why do some people develop substance use disorders while others can use recreationally without problems?

Development of SUD involves complex interactions between genetic predisposition, individual neurobiology, environmental factors, and psychosocial circumstances. Approximately 40-60% of addiction risk is inherited, affecting dopamine sensitivity, impulsivity, stress response, and reward processing. Environmental factors like age of first use (earlier use increases risk), trauma exposure, stress levels, family dysfunction, peer influence, and drug availability substantially influence whether someone develops an SUD. Psychological factors including personality traits (sensation-seeking, impulsivity), coping skills, and co-occurring mental health conditions affect vulnerability. Additionally, different substances have different addiction potential based on how quickly they raise dopamine. No single factor determines SUD development; rather, higher accumulation of risk factors creates greater vulnerability. This multifactorial model prevents misconceptions that SUDs result from moral weakness.

Can substance withdrawal be life-threatening, and why do some substances produce dangerous withdrawal while others don't?

Yes, withdrawal from some substances can be life-threatening, particularly alcohol and benzodiazepines. These substances can cause seizures and delirium tremens (hallucinations, disorientation, autonomic hyperactivity, cardiovascular collapse), requiring medical monitoring. These are dangerous because they work through GABA suppression. Chronic use causes the brain to reduce GABA sensitivity. Suddenly stopping creates severe neuroinhibition with dangerous consequences.

Opioid withdrawal, while extremely uncomfortable (muscle aches, sweating, anxiety, gastrointestinal distress), is rarely life-threatening in healthy individuals. Stimulant withdrawal (cocaine, methamphetamine) produces psychological distress but minimal medical danger. Hallucinogen withdrawal produces minimal physical symptoms. This difference reflects how different drugs affect neural systems. Central nervous system depressants create physiological danger during withdrawal because the brain adapted to their suppressive effects. Stimulants and opioids primarily affect reward and pain pathways where withdrawal is uncomfortable but not medically dangerous.

What is the role of dopamine in addiction, and why is understanding dopamine important?

Dopamine, a neurotransmitter, plays a central role in the brain's reward system and motivation circuits. Most addictive substances increase dopamine in the nucleus accumbens, creating powerful reinforcement driving repeated substance-seeking behavior. Initially, substance use produces a dopamine surge creating intense pleasure and reinforcing drug-taking. With chronic use, the brain's reward system becomes less sensitive (neuroadaptation), requiring escalating doses for the same effect (tolerance) and making natural rewards seem dull.

This dopamine dysregulation explains why individuals with addiction continue using despite serious negative consequences. Their brain's motivational system has reorganized around drug-seeking. Understanding dopamine is important because it explains addiction as a biological brain disorder affecting motivation and decision-making, not simply a character flaw. This understanding reduces stigma and highlights why treatment must address underlying neurobiological changes, not just willpower.

Why are flashcards effective for studying substance use disorders?

Flashcards are particularly effective for SUDs because this topic requires rapid recall of diagnostic criteria, symptom profiles, withdrawal syndromes, and treatment information. The DSM-5 diagnostic criteria involve precise, distinguishable symptoms students must memorize and apply to case presentations. Flashcards force active recall (the most effective study method), requiring you to generate answers rather than passively reading.

For substance-specific content like withdrawal syndromes and treatments, flashcards enable quick drilling organized by substance class. Creating flashcards forces you to distill complex concepts into essential information, deepening understanding. The format works well for pairing concepts (substance class with primary effects, dopamine's role with addiction mechanisms) and practicing differential diagnosis scenarios. Regular flashcard review prevents forgetting, particularly important for comprehensive exams covering numerous substance classes and treatment modalities.